TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2060150

Group type: EXPERIMENTAL
Intervention: GHRH (1-29)NH2 10 micrograms/kg/h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pyridostigmine 60 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6340575

Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 19

Group type: COMPARATOR
Intervention: Quinidine
Number of subjects: 19
Study: 31814452

Group type: EXPERIMENTAL
Intervention: 15 mg/kg intravenous bolus of tranexamic acid (TXA) in high-risk patients (Hb < 13.0 g/dL)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: 15 mg/kg intravenous bolus of tranexamic acid (TXA) in low-risk patients (Hb ≥ 13.0 g/dL)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control group (no TXA) in high-risk patients
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control group (no TXA) in low-risk patients
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: TXA in both groups
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: TXA in high-risk patients
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: TXA in low-risk patients
Number of subjects: 256
Study: 28581335

Group type: COMPARATOR
Intervention: Daily diary writing
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Structured biographical writing
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Unstructured biographical writing
Number of subjects: 119
Study: 26991138

Group type: EXPERIMENTAL
Intervention: 50 μg/kg anti-D globulin
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1 g/kg IV immune globulin (IVIG)
Number of subjects: 60
Study: 25792578

Group type: EXPERIMENTAL
Intervention: Pocket-size ultrasound examinations performed by medical residents
Number of subjects: 199
Study: 23765409

Group type: EXPERIMENTAL
Intervention: Earlier generic switches within the index ATC code
Number of subjects: 2476

Group type: EXPERIMENTAL
Intervention: Having had more than five earlier switches within other ATC codes
Number of subjects: 2476

Group type: EXPERIMENTAL
Intervention: Having negative views on generic medicines
Number of subjects: 2476

Group type: COMPARATOR
Intervention: Generic substitution
Number of subjects: 2476
Study: 19874340

Group type: EXPERIMENTAL
Intervention: Flashlamp-pumped dye laser (FPDL) with 0.45 ms pulse duration tuned to 585 nm
Number of subjects: 24

Group type: COMPARATOR
Intervention: Long-pulse-duration dye laser (LPDL) with 1.5 or 3.0 ms pulse duration tuned to 595 nm
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both lasers
Number of subjects: 24
Study: 17965444

Group type: EXPERIMENTAL
Intervention: Disulfiram (DIS) 200 mg per day
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX) 50 mg per day
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Acamprosate (ACA) 1998 mg per day
Number of subjects: 243

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 243
Study: 15904629

Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 173
Study: 12904486

Group type: EXPERIMENTAL
Intervention: +30 degrees rotation during center-out-and-back reaching movements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: -30 degrees rotation during different tasks (continuous tracking, figure-eight drawing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (never experienced the opposite rotation)
Number of subjects: 0
Study: 10561144

Group type: EXPERIMENTAL
Intervention: Neutral sodium phosphate (Na(2)HPO(4))
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sodium chloride (NaCl)
Number of subjects: 28
Study: 8991468

Group type: EXPERIMENTAL
Intervention: Propofol (2 mg/kg induction, 15-20 mg/kg x h maintenance with 30% O2 in air)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Propofol (2 mg/kg induction, 10-15 mg/kg x h maintenance with N2O)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Thiopentone (5 mg/kg induction, 0.8-1.5 Vol% isoflurane maintenance with N2O in 30% O2)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Isoflurane (0.8-1.5 Vol% with N2O in 30% O2)
Number of subjects: 130
Study: 1652604

Group type: EXPERIMENTAL
Intervention: SK&F 104353 (963 +/- 43.7 micrograms)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 6139671

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (100 mg three times a day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30623907

Group type: EXPERIMENTAL
Intervention: Spirometry variables including forced vital capacity, forced expiratory volume in 1 second, ratio between the two, peak expiratory flow rate, forced expiratory flow between 25% and 75% expired volume
Number of subjects: 751
Study: 28947757

Group type: EXPERIMENTAL
Intervention: RD + H2O2 photolysis
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: RD followed by minocycline chloride gel
Number of subjects: 53

Group type: COMPARATOR
Intervention: RD alone
Number of subjects: 53
Study: 25873142

Group type: EXPERIMENTAL
Intervention: Patient Activation and Education (PAE) including text messaging, print and web-based tutorials over 12 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PAE plus physician activation (PAE + MD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PAE plus physician activation, plus teledermoscopy (PAE + MD + TD)
Number of subjects: 0
Study: 23538523

Group type: EXPERIMENTAL
Intervention: DTaP‐IPV‐Hep B‐PRP‐T vaccine coadministered with MMR+V
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: MMR+V coadministered with DTaP‐IPV‐Hep B‐PRP‐T vaccine
Number of subjects: 567

Group type: COMPARATOR
Intervention: Control DTwP‐Hib, hepatitis B and oral poliovirus vaccines
Number of subjects: 567
Study: 21418883

Group type: EXPERIMENTAL
Intervention: Yousilin R
Number of subjects: 211

Group type: COMPARATOR
Intervention: Novolin R
Number of subjects: 211
Study: 20035636

Group type: EXPERIMENTAL
Intervention: Strengths and Difficulties Questionnaire with Impact Supplement (SDQ)
Number of subjects: 2066

Group type: EXPERIMENTAL
Intervention: Pediatric Symptom Checklist (PSC)
Number of subjects: 2066

Group type: EXPERIMENTAL
Intervention: PSYBOBA
Number of subjects: 2066
Study: 16963137

Group type: EXPERIMENTAL
Intervention: Rivastigmine 3mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 14551368

Group type: EXPERIMENTAL
Intervention: Bicarbonate concentration 32 mmol/l (modality A)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Bicarbonate concentration 26 mmol/l (modality B)
Number of subjects: 26
Study: 10841169

Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg/day
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Risedronate 2.5 mg/day
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Combined risedronate treatment groups
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study: 9093797

Group type: EXPERIMENTAL
Intervention: Aceclofenac (100 mg twice daily)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Piroxicam (20 mg once daily and placebo once daily)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Aceclofenac
Number of subjects: 240

Group type: COMPARATOR
Intervention: Piroxicam
Number of subjects: 240
Study: 1301246

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 2863596

Group type: EXPERIMENTAL
Intervention: Thrombolysis (intracoronary streptokinase up to 250,000 U, with some receiving intravenous streptokinase 500,000 U)
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 533

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 533
Study: 30060984

Group type: EXPERIMENTAL
Intervention: Everolimus low-exposure (LE)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Everolimus high-exposure (HE)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Everolimus (both LE and HE)
Number of subjects: 35
Study: 28318290

Group type: EXPERIMENTAL
Intervention: Parenting stress (personal distress)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Parenting stress (child rearing stress)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Negative affectivity
Number of subjects: 164
Study: 26429652

Group type: EXPERIMENTAL
Intervention: Brazil nuts (15 to 30 g, 3 days/week)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (no Brazil nuts)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Macapá group
Number of subjects: 129
Study: 24170749

Group type: EXPERIMENTAL
Intervention: High-protein (HP) meal
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: High-fat (HF) meal
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: High-fat/high-protein (HF/HP) meal
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: High-protein (HP) meals
Number of subjects: 33
Study: 21207228

Group type: EXPERIMENTAL
Intervention: Paclitaxel (100 mg/m² by intravenous infusion over 3 hours)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Protease inhibitors (not specified)
Number of subjects: 34
Study: 19960293

Group type: EXPERIMENTAL
Intervention: Herbst appliance
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Functional Mandibular Advancer
Number of subjects: 42
Study: 18257349

Group type: EXPERIMENTAL
Intervention: Acupuncture plus ear point tapping and pressing therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sibutramine (10 mg orally once daily)
Number of subjects: 50
Study: 15051195

Group type: EXPERIMENTAL
Intervention: ATT sequence (argon laser trabeculoplasty - trabeculectomy - trabeculectomy)
Number of subjects: 581

Group type: EXPERIMENTAL
Intervention: TAT sequence (trabeculectomy - argon laser trabeculoplasty - trabeculectomy)
Number of subjects: 581

Group type: EXPERIMENTAL
Intervention: ATT sequence
Number of subjects: 581

Group type: EXPERIMENTAL
Intervention: TAT sequence
Number of subjects: 581

Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 581
Study: 11715639

Group type: EXPERIMENTAL
Intervention: Potassium citrate (PC)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Potassium-sodium citrate (PSC)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Calcium-sodium citrate (CSC)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Urinary citrate elevation (urine A)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Urinary pH elevation (urine B)
Number of subjects: 25
Study: 11783269

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM) combined with hypoglycemic agent
Number of subjects: 52

Group type: COMPARATOR
Intervention: Hypoglycemic agent alone
Number of subjects: 52
Study: 7797783

Group type: EXPERIMENTAL
Intervention: Routine cleaning measures including daily cleaning of smooth floors, weekly laundering of sheets, and monthly cleaning of soft toys; use of synthetic mattress covers.
Number of subjects: 30
Study: 2194867

Group type: EXPERIMENTAL
Intervention: Amox-CA (Augmentin)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Ampicillin-metronidazole +/- aminoglycoside
Number of subjects: 101
Study: 384920

Group type: EXPERIMENTAL
Intervention: Mechanical percussion physiotherapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Manual percussion physiotherapy
Number of subjects: 14
Study: 30903613

Group type: EXPERIMENTAL
Intervention: AE + B + Ad (acid etching + Biosilicate + total-etch adhesive)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: B (Biosilicate)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 30
Study: 26425932

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted LP
Number of subjects: 111

Group type: COMPARATOR
Intervention: Conventional LP
Number of subjects: 111
Study: 25460095

Group type: EXPERIMENTAL
Intervention: Risky driving motor vehicle commercial condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-risky driving motor vehicle commercial condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control non-motor vehicle commercial condition
Number of subjects: 0
Study: 23649578

Group type: EXPERIMENTAL
Intervention: Diode Laser (DL)
Number of subjects: 54

Group type: COMPARATOR
Intervention: 0.4% Stannous Fluoride Gel
Number of subjects: 54

Group type: COMPARATOR
Intervention: 5% Potassium Nitrate Gel
Number of subjects: 54
Study: 21735693

Group type: EXPERIMENTAL
Intervention: Metformin therapy (1700 mg daily for 6 months)
Number of subjects: 30
Study: 20104753

Group type: EXPERIMENTAL
Intervention: IVIG 400 mg/(kg x d) for 5 days or IVIG 1 g/(kg x d) for 2 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ganciclovir (GCV) 5-10 mg/(kg x d) for 5 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 48
Study: 16916184

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous anaesthesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled anaesthetics
Number of subjects: 0
Study: 12625640

Group type: EXPERIMENTAL
Intervention: Transcutaneous NMES
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular EMG-controlled NMES
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neuroprostheses systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NMES technology
Number of subjects: 0
Study: 10648330

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg ketamine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 8887920

Group type: COMPARATOR
Intervention: argon laser treatment (ALT)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: double-frequency Nd:YAG laser treatment (NdLT)
Number of subjects: 42
Study: 1726998

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 3400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3400
Study: 6307964

Group type: EXPERIMENTAL
Intervention: 750 mg oral dose of sultamicillin
Number of subjects: 6

Group type: COMPARATOR
Intervention: IV dose of 441 mg ampicillin and 294 mg sulbactam
Number of subjects: 6
Study: 3517643

Group type: EXPERIMENTAL
Intervention: Penicillamine (10 mg/kg/day)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (6 mg/kg/day)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study: 30064404

Group type: EXPERIMENTAL
Intervention: Sensitivity Programme (SP) in Mental Health (1 h)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Mental Health Literacy (MHL) Programme (6 h)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: MHL plus first-person Stigma Reduction (MHL + SR) (7 h)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Control group: waiting list
Number of subjects: 408
Study: 27358263

Group type: EXPERIMENTAL
Intervention: Increased serum folate levels
Number of subjects: 200

Group type: COMPARATOR
Intervention: Healthy participants without CRA
Number of subjects: 200
Study: 25440796

Group type: EXPERIMENTAL
Intervention: Alirocumab (75-150 mg biweekly injections)
Number of subjects: 18000

Group type: COMPARATOR
Intervention: Placebo (matching injections)
Number of subjects: 18000
Study: 22753208

Group type: EXPERIMENTAL
Intervention: Antihypertensive agents for approximately 12 months
Number of subjects: 108
Study: 19697090

Group type: EXPERIMENTAL
Intervention: Resurfacing arthroplasty
Number of subjects: 107

Group type: COMPARATOR
Intervention: Large-head metal-on-metal total hip arthroplasty
Number of subjects: 107
Study: 18310581

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy plus treatment as usual
Number of subjects: 90

Group type: COMPARATOR
Intervention: Treatment as usual only
Number of subjects: 90
Study: 15964445

Group type: EXPERIMENTAL
Intervention: Medical Emergency Team (MET) system
Number of subjects: 23
Study: 12678365

Group type: EXPERIMENTAL
Intervention: Distal femoral derotation osteotomy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Proximal femoral derotation osteotomy
Number of subjects: 28
Study: 11168249

Group type: EXPERIMENTAL
Intervention: Maxillary long-bar implant overdentures with palatal coverage
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Maxillary long-bar implant overdentures without palatal coverage
Number of subjects: 13

Group type: COMPARATOR
Intervention: New conventional maxillary prostheses
Number of subjects: 13
Study: 9027956

Group type: EXPERIMENTAL
Intervention: Bioartificial liver (BAL) based on pig hepatocytes attached to microcarriers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extracorporeal liver assist device (ELAD) containing a human liver‐derived tumor cell line
Number of subjects: 0
Study: 1283586

Group type: EXPERIMENTAL
Intervention: Calcium antagonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salt-restricted diet
Number of subjects: 0
Study: 6133987

Group type: EXPERIMENTAL
Intervention: Restricted sodium diet
Number of subjects: 28

Group type: COMPARATOR
Intervention: General health package (control)
Number of subjects: 28
Study: 31888944

Group type: EXPERIMENTAL
Intervention: Free and easily accessible medicines (intervention)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Poor access (control)
Number of subjects: 524
Study: 30262460

Group type: EXPERIMENTAL
Intervention: Weighted genetic risk score (GRS) derived from 204 variants representative of 160 CAD loci
Number of subjects: 7261

Group type: EXPERIMENTAL
Intervention: Adding the GRS to clinical predictors
Number of subjects: 7261
Study: 26254237

Group type: EXPERIMENTAL
Intervention: GP care with additional exercise therapy (maximum of 12 sessions in the first 3 months and three booster sessions thereafter)
Number of subjects: 203

Group type: COMPARATOR
Intervention: GP care only
Number of subjects: 203
Study: 24870115

Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation support for at least 3 h (3‐6 h) every night
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard medications
Number of subjects: 80
Study: 22730862

Group type: EXPERIMENTAL
Intervention: Timely bolus insulin (0.2 iu/kg at aortic cannulation, additional 0.1 iu/kg for BG > 10.0 mmol/L)
Number of subjects: 422

Group type: COMPARATOR
Intervention: Conventional glucose management (historical case-matched controls)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Timely bolus insulin
Number of subjects: 422

Group type: COMPARATOR
Intervention: Conventional glucose management
Number of subjects: 422
Study: 20592005

Group type: COMPARATOR
Intervention: Consistently housed group
Number of subjects: 622

Group type: COMPARATOR
Intervention: Housed at baseline but homeless at final follow-up
Number of subjects: 622

Group type: COMPARATOR
Intervention: All homeless groups
Number of subjects: 622

Group type: COMPARATOR
Intervention: Consistently homeless group
Number of subjects: 622
Study: 18315977

Group type: EXPERIMENTAL
Intervention: CNC group
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 16463836

Group type: EXPERIMENTAL
Intervention: Extracranial venous drainage evaluation using MR Venography and flow measurements in IIH patients
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group of healthy subjects, 8 subjects
Number of subjects: 8
Study: 12185702

Group type: EXPERIMENTAL
Intervention: Maternity School training program
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 87
Study: 11486156

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg three times a day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9045106

Group type: EXPERIMENTAL
Intervention: Inactivated Lactobacillus acidophilus LB with rehydratant treatment for acute enteritis
Number of subjects: 63

Group type: COMPARATOR
Intervention: No bacteriotherapeutic drug (control group)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Inactivated Lactobacillus acidophilus with antibiotic therapy for extraintestinal pathologies
Number of subjects: 63
Study: 2003833

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiosensitizers (hyperbaric oxygen, misonidazole)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Irradiation of the para-aortic nodes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-emptive chemotherapy with cisplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elective total cystectomy
Number of subjects: 0
Study: 6733040

Group type: EXPERIMENTAL
Intervention: Short-contact dithranol therapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Ingram regime
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both regimes
Number of subjects: 43
Study: 30879707

Group type: EXPERIMENTAL
Intervention: Weekly low-grade (I-II) Kaltenborn manual mobilization of the hands
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (untreated hand)
Number of subjects: 20
Study: 30006117

Group type: EXPERIMENTAL
Intervention: Single-implant mandibular overdentures (SIMO)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional complete dentures (CCD)
Number of subjects: 84
Study: 26828801

Group type: EXPERIMENTAL
Intervention: Paraspinous lidocaine injection, analgesics, and exercises (LID-INJ)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Sham paraspinous lidocaine injection, analgesics, and exercises (SH-INJ)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Analgesics and exercises (STD-TTR)
Number of subjects: 378
Study: 24249680

Group type: EXPERIMENTAL
Intervention: Pharmacist-initiated multidisciplinary strategy (education, pain medication management, physiotherapy-guided exercise, communication with primary care physician)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care and a pamphlet
Number of subjects: 0
Study: 23113511

Group type: EXPERIMENTAL
Intervention: Non-thermal, non-ablative CO(2) laser therapy (NACLT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (inactive probe)
Number of subjects: 10
Study: 19879576

Group type: EXPERIMENTAL
Intervention: Closed reduction and internal fixation with three cancellous screws
Number of subjects: 455

Group type: COMPARATOR
Intervention: Uncemented hemiarthroplasty
Number of subjects: 455
Study: 18040672

Group type: COMPARATOR
Intervention: Sildenafil plus placebo
Number of subjects: 55

Group type: COMPARATOR
Intervention: Bosentan plus placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Sildenafil plus bosentan
Number of subjects: 55